Diabetes Care:在青少年T1D患者中,血浆尿酸水平不能用来评价心肾功能

2016-03-26 崔倩 译 MedSci原创

在青少年1型糖尿病(T1D)患者中,血浆尿酸(PUA)和肾脏和心血管参数之间的关系还不是很清楚。研究人员的目的是探索性分析研究青少年1型糖尿病患者中PUA和估计肾小球滤过率(eGFR),尿白蛋白肌酐比值(ACR),血压,血管内皮功能和动脉僵硬度之间的关联。研究人员也在健康对照(HC)参与者中进行了研究对这些。在青少年1型糖尿病心肾干预试验(AdDIT)中,研究人员共招募188例T1D患者和65例H

在青少年I型糖尿病(T1D)患者中,血浆尿酸(PUA)和肾脏和心血管参数之间的关系还不是很清楚。研究人员的目的是探索性分析研究青少年1型糖尿病患者的PUA和肾小球滤过率(eGFR)、尿白蛋白肌酐比值(ACR)、血压、血管内皮功能和动脉硬化程度之间的关联。研究人员也在健康对照(HC)参与者中进行了研究对这些。

在青少年1型糖尿病心肾干预试验(AdDIT)中,研究人员共招募188例T1D患者和65例HC参与者。研究人员对基线PUA、eGFR胱抑素C、ACR、血压、血流介导的舒张功能(FMD)和颈动脉、股动脉脉搏波速度(PWV)进行了测定。

I型糖尿病患者的PUA低于HC参与者(分别为242±55 vs 306±74μmol/L;P<0.0001)。在1型糖尿病患者中,较高的PUA与eGFR呈负相关,即使调整了基线临床人口统计学特征后(R=-0.48,P<0.0001)。在I型糖尿病患者中,调整潜在混杂因素,如表皮生长因子受体后,PUA与ACR无关。在T1D或HC受试者中,相对于心血管参数,PUA水平与收缩压、FMD、或PWV无关。

甚至在生理范围内,T1D青少年患者的PUA水平也显著低于HC受试者。在T1D患者中,I型糖尿病患者的PUA和EGFR之间存在反比关系。目前还没有观察到与ACR、血压、动脉硬化、或血管内皮功能之间的关联。因此,与成人相反,在T1D青少年患者中,PUA可能与心肾异常无关。

原始出处:

Yuliya Lytvyn,Farid H. Mahmud,Denis Daneman,et al.Association Between Plasma Uric Acid Levels and Cardiorenal Function in Adolescents With Type 1 Diabetes,Diabetes Care,2016.3.25

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1850573, encodeId=cee018505e3da, content=<a href='/topic/show?id=46c682469e4' target=_blank style='color:#2F92EE;'>#肾功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82469, encryptionId=46c682469e4, topicName=肾功能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28d456, createdName=yese, createdTime=Thu May 19 09:50:00 CST 2016, time=2016-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1743747, encodeId=cd541e437479f, content=<a href='/topic/show?id=30fe513e311' target=_blank style='color:#2F92EE;'>#心肾功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51373, encryptionId=30fe513e311, topicName=心肾功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba7c35209176, createdName=tamgche, createdTime=Mon Aug 01 12:50:00 CST 2016, time=2016-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1637299, encodeId=87db163e299d3, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Jul 14 09:50:00 CST 2016, time=2016-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901363, encodeId=67cb19013630d, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Fri Nov 25 00:50:00 CST 2016, time=2016-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759653, encodeId=ab391e596538d, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Dec 17 01:50:00 CST 2016, time=2016-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444141, encodeId=94eb1444141ee, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Mon Mar 28 12:50:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519099, encodeId=11ce151909935, content=<a href='/topic/show?id=8a8d1e03926' target=_blank style='color:#2F92EE;'>#T1D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17039, encryptionId=8a8d1e03926, topicName=T1D)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=677711243794, createdName=huhuaidong391, createdTime=Mon Mar 28 12:50:00 CST 2016, time=2016-03-28, status=1, ipAttribution=)]
    2016-05-19 yese
  2. [GetPortalCommentsPageByObjectIdResponse(id=1850573, encodeId=cee018505e3da, content=<a href='/topic/show?id=46c682469e4' target=_blank style='color:#2F92EE;'>#肾功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82469, encryptionId=46c682469e4, topicName=肾功能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28d456, createdName=yese, createdTime=Thu May 19 09:50:00 CST 2016, time=2016-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1743747, encodeId=cd541e437479f, content=<a href='/topic/show?id=30fe513e311' target=_blank style='color:#2F92EE;'>#心肾功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51373, encryptionId=30fe513e311, topicName=心肾功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba7c35209176, createdName=tamgche, createdTime=Mon Aug 01 12:50:00 CST 2016, time=2016-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1637299, encodeId=87db163e299d3, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Jul 14 09:50:00 CST 2016, time=2016-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901363, encodeId=67cb19013630d, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Fri Nov 25 00:50:00 CST 2016, time=2016-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759653, encodeId=ab391e596538d, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Dec 17 01:50:00 CST 2016, time=2016-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444141, encodeId=94eb1444141ee, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Mon Mar 28 12:50:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519099, encodeId=11ce151909935, content=<a href='/topic/show?id=8a8d1e03926' target=_blank style='color:#2F92EE;'>#T1D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17039, encryptionId=8a8d1e03926, topicName=T1D)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=677711243794, createdName=huhuaidong391, createdTime=Mon Mar 28 12:50:00 CST 2016, time=2016-03-28, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1850573, encodeId=cee018505e3da, content=<a href='/topic/show?id=46c682469e4' target=_blank style='color:#2F92EE;'>#肾功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82469, encryptionId=46c682469e4, topicName=肾功能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28d456, createdName=yese, createdTime=Thu May 19 09:50:00 CST 2016, time=2016-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1743747, encodeId=cd541e437479f, content=<a href='/topic/show?id=30fe513e311' target=_blank style='color:#2F92EE;'>#心肾功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51373, encryptionId=30fe513e311, topicName=心肾功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba7c35209176, createdName=tamgche, createdTime=Mon Aug 01 12:50:00 CST 2016, time=2016-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1637299, encodeId=87db163e299d3, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Jul 14 09:50:00 CST 2016, time=2016-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901363, encodeId=67cb19013630d, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Fri Nov 25 00:50:00 CST 2016, time=2016-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759653, encodeId=ab391e596538d, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Dec 17 01:50:00 CST 2016, time=2016-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444141, encodeId=94eb1444141ee, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Mon Mar 28 12:50:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519099, encodeId=11ce151909935, content=<a href='/topic/show?id=8a8d1e03926' target=_blank style='color:#2F92EE;'>#T1D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17039, encryptionId=8a8d1e03926, topicName=T1D)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=677711243794, createdName=huhuaidong391, createdTime=Mon Mar 28 12:50:00 CST 2016, time=2016-03-28, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1850573, encodeId=cee018505e3da, content=<a href='/topic/show?id=46c682469e4' target=_blank style='color:#2F92EE;'>#肾功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82469, encryptionId=46c682469e4, topicName=肾功能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28d456, createdName=yese, createdTime=Thu May 19 09:50:00 CST 2016, time=2016-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1743747, encodeId=cd541e437479f, content=<a href='/topic/show?id=30fe513e311' target=_blank style='color:#2F92EE;'>#心肾功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51373, encryptionId=30fe513e311, topicName=心肾功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba7c35209176, createdName=tamgche, createdTime=Mon Aug 01 12:50:00 CST 2016, time=2016-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1637299, encodeId=87db163e299d3, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Jul 14 09:50:00 CST 2016, time=2016-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901363, encodeId=67cb19013630d, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Fri Nov 25 00:50:00 CST 2016, time=2016-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759653, encodeId=ab391e596538d, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Dec 17 01:50:00 CST 2016, time=2016-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444141, encodeId=94eb1444141ee, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Mon Mar 28 12:50:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519099, encodeId=11ce151909935, content=<a href='/topic/show?id=8a8d1e03926' target=_blank style='color:#2F92EE;'>#T1D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17039, encryptionId=8a8d1e03926, topicName=T1D)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=677711243794, createdName=huhuaidong391, createdTime=Mon Mar 28 12:50:00 CST 2016, time=2016-03-28, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1850573, encodeId=cee018505e3da, content=<a href='/topic/show?id=46c682469e4' target=_blank style='color:#2F92EE;'>#肾功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82469, encryptionId=46c682469e4, topicName=肾功能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28d456, createdName=yese, createdTime=Thu May 19 09:50:00 CST 2016, time=2016-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1743747, encodeId=cd541e437479f, content=<a href='/topic/show?id=30fe513e311' target=_blank style='color:#2F92EE;'>#心肾功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51373, encryptionId=30fe513e311, topicName=心肾功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba7c35209176, createdName=tamgche, createdTime=Mon Aug 01 12:50:00 CST 2016, time=2016-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1637299, encodeId=87db163e299d3, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Jul 14 09:50:00 CST 2016, time=2016-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901363, encodeId=67cb19013630d, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Fri Nov 25 00:50:00 CST 2016, time=2016-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759653, encodeId=ab391e596538d, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Dec 17 01:50:00 CST 2016, time=2016-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444141, encodeId=94eb1444141ee, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Mon Mar 28 12:50:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519099, encodeId=11ce151909935, content=<a href='/topic/show?id=8a8d1e03926' target=_blank style='color:#2F92EE;'>#T1D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17039, encryptionId=8a8d1e03926, topicName=T1D)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=677711243794, createdName=huhuaidong391, createdTime=Mon Mar 28 12:50:00 CST 2016, time=2016-03-28, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1850573, encodeId=cee018505e3da, content=<a href='/topic/show?id=46c682469e4' target=_blank style='color:#2F92EE;'>#肾功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82469, encryptionId=46c682469e4, topicName=肾功能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28d456, createdName=yese, createdTime=Thu May 19 09:50:00 CST 2016, time=2016-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1743747, encodeId=cd541e437479f, content=<a href='/topic/show?id=30fe513e311' target=_blank style='color:#2F92EE;'>#心肾功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51373, encryptionId=30fe513e311, topicName=心肾功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba7c35209176, createdName=tamgche, createdTime=Mon Aug 01 12:50:00 CST 2016, time=2016-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1637299, encodeId=87db163e299d3, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Jul 14 09:50:00 CST 2016, time=2016-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901363, encodeId=67cb19013630d, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Fri Nov 25 00:50:00 CST 2016, time=2016-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759653, encodeId=ab391e596538d, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Dec 17 01:50:00 CST 2016, time=2016-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444141, encodeId=94eb1444141ee, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Mon Mar 28 12:50:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519099, encodeId=11ce151909935, content=<a href='/topic/show?id=8a8d1e03926' target=_blank style='color:#2F92EE;'>#T1D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17039, encryptionId=8a8d1e03926, topicName=T1D)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=677711243794, createdName=huhuaidong391, createdTime=Mon Mar 28 12:50:00 CST 2016, time=2016-03-28, status=1, ipAttribution=)]
    2016-03-28 huagfeg
  7. [GetPortalCommentsPageByObjectIdResponse(id=1850573, encodeId=cee018505e3da, content=<a href='/topic/show?id=46c682469e4' target=_blank style='color:#2F92EE;'>#肾功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82469, encryptionId=46c682469e4, topicName=肾功能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28d456, createdName=yese, createdTime=Thu May 19 09:50:00 CST 2016, time=2016-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1743747, encodeId=cd541e437479f, content=<a href='/topic/show?id=30fe513e311' target=_blank style='color:#2F92EE;'>#心肾功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51373, encryptionId=30fe513e311, topicName=心肾功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ba7c35209176, createdName=tamgche, createdTime=Mon Aug 01 12:50:00 CST 2016, time=2016-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1637299, encodeId=87db163e299d3, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Jul 14 09:50:00 CST 2016, time=2016-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901363, encodeId=67cb19013630d, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Fri Nov 25 00:50:00 CST 2016, time=2016-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759653, encodeId=ab391e596538d, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Dec 17 01:50:00 CST 2016, time=2016-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444141, encodeId=94eb1444141ee, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Mon Mar 28 12:50:00 CST 2016, time=2016-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519099, encodeId=11ce151909935, content=<a href='/topic/show?id=8a8d1e03926' target=_blank style='color:#2F92EE;'>#T1D#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17039, encryptionId=8a8d1e03926, topicName=T1D)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=677711243794, createdName=huhuaidong391, createdTime=Mon Mar 28 12:50:00 CST 2016, time=2016-03-28, status=1, ipAttribution=)]
    2016-03-28 huhuaidong391

相关资讯

Pediatr Diabetes:青年T1D患者血糖控制差增加DKA风险

重度低血糖(SH)和糖尿病酮症酸中毒(DKA)是1型糖尿病(T1D)常见的严重急性并发症。为了确定在1型糖尿病交流中心的儿童和青年队列中,重度低血糖和糖尿病酮症酸中毒发生的频率,以及确定重度低血糖和糖尿病酮症酸发生有关的因素,来自美国耶鲁大学的Eda Cengiza教授及其团队进行了一项研究,该研究发现在青少年和青壮年1型糖尿病患者中,血糖控制差增加糖尿病酮症酸中毒的风险,但不能预防重度低血糖的发

Diabetes Care:炎症基因表达改变或参与T1DM及其并发症的发生

前期的基因表达芯片研究鉴定了1型糖尿病(T1D)患者和胰岛自身抗体阳性受试者之间一些基因表达有差异。为了验证T1D患者中这些基因表达的变化,以及鉴定糖尿病并发症中表达改变的基因,来自佐治亚州摄政大学医学院生物技术和基因组医学中心的Yulan Jin博士等人进行了一项研究,研究发现,由骨髓细胞分泌的炎症介质涉及T1D及其并发症的发生。研究结果在线发表于2013年5月1日的美国《糖尿病治疗》(Diab